Frontline Therapy of Diffuse Large B Cell Lymphoma of the Adult ( 18 to 60 Years Old): Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14 -Rituximab. Multicentric Randomized Prospective Trial.
Diffuse Large B Cell Lymphoma not previously treated
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
3 years Event-free survival ( Kaplan Meier method)
Noel Milpied, MD
Principal Investigator
CHU Bordeaux
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
BRD 04/4-O
NCT00561379
April 2005
May 2013
Name | Location |
---|